Full text is available at the source.
Abstract
Cellular senescence may impair cardiac lymphatic function, contributing to heart failure with preserved ejection fraction (HFpEF).
- The senescence-associated secretory phenotype could exacerbate myocardial interstitial edema and chronic inflammation in HFpEF.
- Lymphatic endothelial dysfunction is proposed as a significant factor in the pathobiology of HFpEF.
- Emerging evidence from molecular geroscience and lymphatic biology supports this novel mechanistic framework.
- Potential therapeutic approaches include senolytic and senomorphic interventions targeting cellular senescence.
- Challenges exist in cardiac lymphatic imaging and drug delivery, particularly in elderly patients with comorbidities.
Simplified